N | Nigella sativa | Placebo | P† |
---|---|---|---|
N = 20 | N = 20 | ||
TSH (mIU/l) | |||
Before | 6.42 ± 3.86 | 8.14 ± 7.28 | 0.35 |
After | 4.13 ± 2.35 | 8.27 ± 7.21 | 0.02 |
P‡ | 0.03 | 0.40 | |
T3 (mmol/l) | |||
Before | 0.92 ± 0.27 | 1.18 ± 0.36 | 0.017 |
After | 1.06 ± 0.34 | 1.16 ± 0.35 | 0.39 |
P‡ | 0.008 | 0.15 | |
T4 (mmol/l) | |||
Before | 8.07 ± 2.56 | 7.97 ± 3.11 | 0.91 |
After | 8.89 ± 1.43 | 7.63 ± 2.23 | 0.04 |
P‡ | 0.21 | 0.32 | |
Anti-TPO (IU/ml) | |||
Before | 294.55 ± 210.05 | 278.10 ± 170.77 | 0.78 |
After | 147.99 ± 158.33 | 274.30 ± 167.20 | 0.01 |
P‡ | 0.019 | 0.28 | |
Nesfatin-1 (ng/ml) | |||
Before | 41.80 ± 28.33 | 25.86 ± 20.91 | 0.049 |
After | 37.63 ± 5.91 | 26.75 ± 23.95 | |
P‡ | 0.34 | 0.69 | |
VEGF (ng/L) | |||
Before | 3521.13 ± 395.95 | 2101.73 ± 339.29 | 0.17 |
After | 2100.17 ± 36,082 | 2100.17 ± 360.82 | 0.25 |
P‡ | 0.02 | 0.99 |